SWOT Analysis
- S
- W
- O
- T
-
Strength (6)
Companies seeing rising net cash flow, and cash from operating activity
-
Weakness (3)
See all stocks where promoters decreased their stake. Promoters decreasing their shareholding in a stock is considered negative for the stock.
-
Opportunity (0)
-
Threats (0)
- Rising Net Cash Flow and Cash from Operating activity
- Companies with Low Debt
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
- Annual Net Profits improving for last 2 years
- Companies with Zero Promoter Pledge
Data not found
Data not found
Technical Analysis
Moving Averages
EMA
SMA
- 5 Day 610.8
- 10 Day 615.8
- 12 Day 617.4
- 20 Day 620.7
- 26 Day 620.5
- 50 Day 608.8
- 100 Day 581.4
- 200 Day 559.5
610.15
-0.96%
Current Price
- Bullish Moving Averages 7
- Bearish Moving Averages 9
Resistance and support
614.58PIVOT
- First Resistance 622.1
- Second Resistance 634.0
- Third Resistance 641.5
- First Support 602.7
- Second Support 595.2
- Third Support 583.3
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
- CAGR IN 10 YEARS
- 11.42%
- 21.20%
- 24.75%
Mar 2026 (CR) |
Mar 2025 (CR) |
Mar 2024 (CR) |
Mar 2023 (CR) |
Mar 2022 (CR) |
||
|---|---|---|---|---|---|---|
| Sales | 407.29 | 343.98 | 288.60 | 315.12 | 275.98 |
|
| Operating Profit | 139.91 | 121.95 | 86.24 | 93.54 | 78.56 |
|
| OP Profit Margin | 34.35 | 35.45 | 29.88 | 29.68 | 28.47 |
|
| Interest | 1.17 | 1.90 | 2.10 | 2.64 | 1.50 |
|
| Profit After Tax | 77.51 | 67.34 | 41.01 | 47.30 | 41.06 |
|
| Cash Profit | 120.79 | 104.04 | 75.09 | 79.35 | 65.53 |
|
| EPS | 17.35 | 30.29 | 18.50 | 21.37 | 18.57 |
|
- CAGR IN 10 YEARS
- 14.40%
- -24.85%
- 20.98%
Mar 2026 (CR) |
Mar 2025 (CR) |
Mar 2024 (CR) |
Mar 2023 (CR) |
Mar 2022 (CR) |
||
|---|---|---|---|---|---|---|
| Equity | 8.93 | 4.45 | 4.43 | 4.43 | 4.42 |
|
| Reserve Surplus | 447.94 | 374.40 | 309.68 | 276.16 | 229.23 |
|
| TOT Debts | 3.33 | 8.52 | 19.19 | 14.99 | 19.03 |
|
| Gross Block | 543.87 | 426.93 | 331.17 | 300.44 | 266.16 |
|
| Capital Work In Progress | 17.99 | 38.10 | 58.57 | 12.31 | 0.31 |
|
| Cash Liquid Investment | 65.06 | 32.94 | 25.79 | 38.83 | 11.27 |
|
| Net Working Capital | 165.41 | 134.90 | 121.36 | 115.44 | 85.81 |
|
| Current Assets | 229.74 | 194.60 | 165.41 | 168.69 | 129.31 |
|
| Current Liabilities | 64.34 | 59.69 | 44.05 | 53.25 | 43.50 |
|
Jun 2026 (CR) |
Mar 2026 (CR) |
Dec 2025 (CR) |
Sep 2025 (CR) |
Jun 2025 (CR) |
||
|---|---|---|---|---|---|---|
| Sales | 109.07 | 109.25 | 98.63 | 101.85 | 97.56 |
|
| Gross Profit | 40.89 | 41.80 | 34.29 | 36.51 | 35.12 |
|
| Gross Profit Margins | 79.25 | 79.45 | 80.44 | 80.24 | 80.73 |
|
| Operating Profit | 37.31 | 39.37 | 32.62 | 34.23 | 33.69 |
|
| OP Profit Margin | 26.20 | 26.88 | 23.86 | 26.16 | 26.22 |
|
| Interest | 0.24 | 0.32 | 0.16 | 0.37 | 0.32 |
|
| Profit After Tax | 21.04 | 21.11 | 17.59 | 19.92 | 18.89 |
|
| Cash Profit | 33.59 | 33.86 | 28.51 | 30.16 | 28.75 |
|
| EPS | 4.71 | 4.73 | 3.96 | 4.46 | 4.25 |
|
- CAGR IN 10 YEARS
- 14.40%
- -24.85%
- 20.98%
Mar 2026 (CR) |
Mar 2025 (CR) |
Mar 2024 (CR) |
Mar 2023 (CR) |
Mar 2022 (CR) |
||
|---|---|---|---|---|---|---|
| PE | 21.95 | 33.02 | 24.04 | 14.70 | 16.96 |
|
| P/BV | 3.72 | 5.87 | 3.14 | 2.48 | 2.98 |
|
| MCAP Sales | 4.18 | 6.46 | 3.42 | 2.21 | 2.52 |
|
| Asset Turnover | 0.90 | 0.91 | 0.88 | 1.10 | 1.10 |
|
| EV/EBITDA | 11.01 | 17.35 | 10.89 | 6.92 | 8.80 |
|
| DEBT/EQUITY | 0.01 | 0.04 | 0.06 | 0.07 | 0.11 |
|
| ROE | 18.55 | 19.44 | 13.66 | 18.40 | 19.19 |
|
| ROCE | 23.21 | 24.14 | 19.43 | 23.15 | 22.69 |
|
Quick Results Snapshot
Q1FY27 Quarterly Result Announced for Vimta Labs Ltd.
Healthcare Services company Vimta Labs announced Q1FY27 results
Financial Highlights:
- Revenue from Operations: The company reported revenue of Rs 1,090.74 million in Q1FY27, representing a YoY growth of 11.79% compared to Rs 975.64 million in Q1FY26. On a QoQ basis, revenue saw a marginal decline of 0.16% from Rs 1,092.45 million in Q4FY26.
- Total Income: Total income for Q1FY27 stood at Rs 1,128.86 million, an increase of 13.67% YoY from Rs 993.13 million in Q1FY26 and an increase of 0.79% QoQ from Rs 1,119.96 million in Q4FY26.
- Profit Before Tax (PBT): The company achieved a PBT of Rs 283.38 million in Q1FY27, growing 12.18% YoY from Rs 252.62 million in Q1FY26. Sequentially, PBT decreased by 2.44% from Rs 290.47 million in Q4FY26.
- Profit After Tax (PAT): Net profit for Q1FY27 was Rs 210.42 million, marking a YoY increase of 11.37% from Rs 188.94 million in Q1FY26. On a QoQ basis, net profit decreased by 0.34% from Rs 211.13 million in Q4FY26.
- Total Comprehensive Income: For Q1FY27, total comprehensive income was Rs 210.27 million, up 11.33% YoY from Rs 188.87 million in Q1FY26, but down 1.70% QoQ from Rs 213.90 million in Q4FY26.
- Earnings Per Share (EPS): Basic EPS for Q1FY27 stood at Rs 4.71, compared to Rs 4.25 in Q1FY26 and Rs 4.73 in Q4FY26. Diluted EPS was Rs 4.66 in Q1FY27 compared to Rs 4.21 in Q1FY26 and Rs 4.62 in Q4FY26.
Business Highlights:
- Segment Performance: The management has identified only one reportable segment, namely "Contract Research and Testing Services".
- Public Private Partnership (PPP): The company operates a National Food Testing Laboratory (NFL) in JNPT, Mumbai under a PPP agreement with the Food Safety and Standards Authority of India (FSSAI). Revenue from operations and lab setup expenses for Q1FY27 includes Rs 0.45 million (compared to Rs 0.11 million in Q1FY26) representing revenues relating to lab setup services provided under this arrangement.
- Employee Stock Options: Pursuant to the 'Vimta Labs Employee Stock Option Plan 2021 (VLESOP-2021)', the nomination and remunerations committee granted 40,500 options to eligible employees on July 20, 2026. The fair value of stock options accounted for as employee compensation expense for Q1FY27 was Rs 8.46 million, compared to Rs 15.19 million in Q1FY26.
- Subsidiary Status: The company confirmed that it does not have any subsidiary, associate, or joint venture entities during the quarter under review.
- Impact of New Labour Code: The company reassessed the impact of changes in the new labour code based on actuarial valuation. While this resulted in an incremental impact of past service cost in gratuity amounting to Rs 16.16 million (presented as exceptional items in FY26), there was no exceptional impact recorded in Q1FY27.
Stocks Comparison
Table
Chart
Company name |
LTP |
Market cap (Cr) |
Return (1Y %) |
Risk (Std. Dev.) |
PE Ratio |
Financial Year |
|---|---|---|---|---|---|---|
| Vimta Labs Ltd | 610.15 | 2,727.36 | -20.16 | 0.16 | 34.20 | Mar 2026 |
| Manipal Health Enterprises Ltd | 746.10 | 98,140.29 | 11.87 | - | 108.31 | Mar 2026 |
| Molbio Diagnostics Ltd | 1,263.80 | 14,564.03 | 21.32 | - | 88.84 | Mar 2026 |
| Park Medi World Ltd | 285.10 | 12,314.35 | 92.70 | 0.13 | 41.51 | Mar 2026 |
| Suven Life Sciences Ltd | 335.45 | 9,478.57 | 44.40 | 0.23 | -26.93 | Mar 2026 |
| Nephrocare Health Services Ltd | 749.45 | 7,536.40 | 59.03 | 0.10 | 88.57 | Mar 2026 |
| Kovai Medical Center & Hospital Ltd | 6,153.50 | 6,731.93 | 12.13 | - | 26.29 | Mar 2026 |
| Artemis Medicare Services Ltd | 340.85 | 5,395.87 | 37.90 | 0.10 | 47.40 | Mar 2026 |
| KMC Speciality Hospitals (India) Ltd | 159.61 | 2,603.24 | 11.51 | - | 46.73 | Mar 2026 |
| Dr Agarwals Eye Hospital Ltd | 5,200.00 | 2,513.07 | 8.61 | 0.03 | 33.01 | Mar 2026 |
| Suraksha Diagnostic Ltd | 353.40 | 1,840.53 | 10.33 | 0.14 | 52.50 | Mar 2026 |
| Krsnaa Diagnostics Ltd | 557.85 | 1,809.59 | -35.01 | - | 18.59 | Mar 2026 |
| Tarsons Products Ltd | 331.50 | 1,763.79 | 7.46 | - | 158.56 | Mar 2026 |
| Shalby Ltd | 136.70 | 1,476.49 | -48.54 | 0.17 | 39.54 | Mar 2026 |
| Gujarat Kidney & Super Speciality Ltd | 175.17 | 1,381.10 | 67.56 | 0.13 | 82.90 | Mar 2025 |
| GPT Healthcare Ltd | 162.79 | 1,335.77 | 7.84 | 0.09 | 28.25 | Mar 2026 |
| 3B Blackbio DX Ltd | 1,369.30 | 1,175.23 | 5.18 | 0.09 | 20.85 | Mar 2025 |
| One Global Service Provider Ltd | 547.90 | 1,070.76 | -3.08 | - | 14.53 | Mar 2026 |
| Laxmi Dental Ltd | 193.18 | 1,063.06 | -42.68 | 0.15 | 34.36 | Mar 2026 |
| Gaudium IVF and Women Health Ltd | 111.35 | 810.48 | 38.74 | 0.31 | 34.94 | Mar 2025 |
| Lotus Eye Hospital & Institute Ltd | 114.97 | 239.10 | -6.25 | 0.12 | 1660.71 | Mar 2026 |
| Take Ltd | 15.84 | 234.33 | 50.86 | 0.33 | 18.24 | Mar 2026 |
| Sunil Healthcare Ltd | 75.80 | 77.73 | 10.98 | - | 20.76 | Mar 2025 |
| Deccan Health Care Ltd | 11.38 | 0.00 | -43.04 | - | 11.05 | Mar 2025 |
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Sep 16, 2026Allotment of Employee Stock Options under "Vimta Labs Employee Stock Option Plan 2021".
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Sep 08, 2026Intimation of Schedule of Analyst/ Institutional Investor Meet.
Announcement under Regulation 30 (LODR)-Credit Rating
Sep 02, 2026Disclosure on Credit Rating.
Clarification Regarding Increase In Volume Of Our Securities Across Exchanges.
Sep 01, 2026Reply to the clarification regarding increase in volume.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Aug 29, 2026Intimation of Schedule of Analyst/Institutional Investor Meet.
| Ex-Date | Purpose | Notes |
|---|---|---|
| 2026-07-20 | Quarterly Results | |
| 2026-05-06 | Audited Results & Final Dividend | |
| 2026-01-28 | Quarterly Results | |
| 2025-11-03 | Quarterly Results | |
| 2025-07-17 | Quarterly Results | |
| 2025-04-28 | Audited Results, Dividend & Bonus issue | |
| 2025-01-24 | Quarterly Results | |
| 2024-11-08 | Quarterly Results | |
| 2024-07-17 | Quarterly Results | |
| 2024-05-18 | Audited Results & Final Dividend | |
| 2024-03-30 | Amalgamation | |
| 2024-01-31 | Quarterly Results | |
| 2023-10-30 | Quarterly Results | |
| 2023-07-28 | Quarterly Results | |
| 2023-05-03 | Audited Results & Final Dividend | |
| 2023-01-27 | Quarterly Results | |
| 2022-10-27 | Quarterly Results | |
| 2022-07-25 | Quarterly Results | |
| 2022-05-12 | Audited Results & Dividend | |
| 2022-01-20 | Quarterly Results | |
| 2021-10-23 | Quarterly Results | |
| 2021-07-22 | Quarterly Results | |
| 2021-05-14 | Audited Results & Dividend | |
| 2021-01-23 | Quarterly Results | |
| 2020-10-15 | Quarterly Results | |
| 2020-08-10 | Quarterly Results | |
| 2020-06-15 | Audited Results | |
| 2020-01-30 | Quarterly Results | |
| 2019-11-09 | Quarterly Results | |
| 2019-07-27 | Quarterly Results | |
| 2019-05-11 | Audited Results & Dividend | |
| 2019-02-06 | Quarterly Results | |
| 2018-11-09 | Quarterly Results | |
| 2018-08-13 | Quarterly Results | |
| 2018-05-11 | Audited Results & Dividend | |
| 2018-01-31 | Quarterly Results | |
| 2017-12-01 | Quarterly Results | |
| 2017-08-17 | Quarterly Results | |
| 2017-04-22 | Audited Results & Dividend | |
| 2017-02-11 | Quarterly Results | |
| 2016-11-12 | Quarterly Results | |
| 2016-07-14 | Quarterly Results | |
| 2016-05-16 | Audited Results & Dividend | |
| 2016-01-28 | Quarterly Results | |
| 2015-11-06 | Quarterly Results | |
| 2015-07-17 | Quarterly Results | |
| 2015-05-28 | Audited Results & Dividend | Appointed Mr. M. Murali Mohan Rao, Associate Vice President - Finance, as Chief Financial Officer to take the charge of office of CFO effective from July 01, 2015. |
| 2015-02-09 | Quarterly Results | |
| 2014-11-08 | Quarterly Results | |
| 2014-07-31 | Quarterly Results | |
| 2014-05-17 | Audited Results | |
| 2014-01-25 | Quarterly Results | |
| 2013-11-07 | Quarterly Results | |
| 2013-07-15 | Quarterly Results | |
| 2013-04-27 | Audited Results & Dividend | |
| 2013-02-02 | Quarterly Results | |
| 2012-11-03 | Quarterly Results | |
| 2012-07-16 | Quarterly Results | |
| 2012-05-21 | Audited Results | |
| 2012-01-30 | Quarterly Results | |
| 2011-07-22 | Quarterly Results | |
| 2011-05-13 | Audited Results & Dividend | |
| 2011-01-29 | Quarterly Results | |
| 2010-10-29 | Quarterly Results | |
| 2010-07-28 | Quarterly Results | |
| 2010-05-12 | Audited Results & Dividend | |
| 2010-01-25 | Quarterly Results | |
| 2009-10-22 | Quarterly Results | |
| 2009-07-23 | Quarterly Results | |
| 2009-04-27 | Audited Results & Dividend | |
| 2009-01-16 | Quarterly Results | |
| 2008-10-30 | Quarterly Results | |
| 2008-07-30 | Quarterly Results | |
| 2008-04-21 | Audited Results & Dividend | |
| 2008-01-18 | Quarterly Results | |
| 2007-10-26 | Quarterly Results | |
| 2007-07-28 | Quarterly Results | |
| 2007-04-26 | Audited Results & Dividend | |
| 2007-01-25 | Quarterly Results | |
| 2006-10-27 | Quarterly Results | |
| 2006-07-17 | Quarterly Results | |
| 2006-04-24 | Accounts & Dividend | |
| 2006-03-23 | Preferential allotment | To consider allotment of 4064690 Equity Shares of Rs 2/- each at a premium of Rs 188/- per share to the investors on preferential allotment basis. |
| 2006-01-09 | Quarterly Results & Stock Split | |
| 2005-10-17 | Quarterly Results | |
| 2005-07-16 | Quarterly Results | |
| 2005-04-20 | Final Dividend & Accounts | |
| 2005-01-12 | Quarterly Results | |
| 2004-07-12 | Quarterly Results & Dividend | |
| 2004-04-16 | Accounts | |
| 2003-10-16 | Quarterly Results & Interim Dividend | |
| 2003-07-12 | Quarterly Results | |
| 2003-04-19 | Dividend & Accounts | |
| 2003-01-11 | Quarterly Results | |
| 2002-10-26 | Quarterly Results | |
| 2002-07-13 | Quarterly Results | |
| 2002-04-12 | Dividend & Accounts | |
| 2002-01-28 | Quarterly Results | |
| 2001-10-29 | Quarterly Results | |
| 2001-07-30 | Quarterly Results | |
| 2001-06-25 | Accounts | |
| 2001-01-30 | Quarterly Results | |
| 2000-10-23 | Quarterly Results | |
| 2000-07-31 | Quarterly Results | |
| 2000-04-01 | Quarterly Results | |
| 2000-01-29 | Quarterly Results | |
| 1999-10-28 | Quarterly Results | |
| 1999-07-26 | Quarterly Results | |
| 1999-05-28 | Accounts | |
| 1999-01-30 | Quarterly Results | |
| 1998-10-30 | Quarterly Results | |
| 1998-07-30 | Quarterly Results | |
| 1998-06-29 | Accounts | |
| 1997-06-04 | Accounts |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 2026-06-18 | 2 | FINAL | 2026-06-18 | Equity Share |
| 2025-05-30 | 2 | FINAL | 2025-05-30 | Equity Share |
| 2024-07-11 | 2 | FINAL | Equity Share | |
| 2023-06-21 | 2 | FINAL | Equity Share | |
| 2022-06-16 | 2 | FINAL | 2022-06-18 | Equity Share |
| 2021-06-25 | 2 | FINAL | 2021-06-28 | Equity Share |
| 2019-07-18 | 2 | FINAL | Equity Share | |
| 2018-08-14 | 2 | FINAL | Equity Share | |
| 2016-08-25 | 1 | FINAL | Equity Share | |
| 2015-08-06 | 1 | FINAL | Equity Share | |
| 2014-06-27 | 2 | FINAL | Equity Share | |
| 2013-05-23 | 0.6 | FINAL | Equity Share | |
| 2011-09-15 | 0.4 | FINAL | Equity Share | |
| 2010-09-23 | 0.8 | FINAL | Equity Share | |
| 2009-09-10 | 0.8 | FINAL | Equity Share | |
| 2008-08-28 | 0.8 | FINAL | Equity Share | |
| 2007-08-02 | 0.8 | FINAL | Equity Share | |
| 2006-06-01 | 0.8 | FINAL | Equity Share | |
| 2005-05-19 | 2 | FINAL | Equity Share | |
| 2004-07-22 | 2 | INTERIM | 2004-07-23 | Equity Share |
| 2004-02-05 | 1.5 | INTERIM | 2004-02-06 | Equity Share |
| 2003-06-05 | 1.5 | FINAL | Equity Share |
| Ex-Date | Old FV | New FV | Record Date |
|---|---|---|---|
| 2006-02-24 | 10 | 2 | 2006-03-03 |
No Data Found
| Event Date | Event |
|---|---|
| Jun 13, 2025 | Bonus |
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
Client name |
Deal Type |
Date |
Action |
Avg. price |
Quantity |
Exchange |
|---|---|---|---|---|---|---|
| Microcurves Trading Private Limited | Bulk | 2026-07-21 |
Purchase |
603.90 | 366,347 | NSE |
| Microcurves Trading Private Limited | Bulk | 2026-07-21 |
Sell |
604.27 | 366,347 | NSE |
| Hrti Private Limited | Bulk | 2025-09-25 |
Purchase |
753.57 | 295,059 | NSE |
| Hrti Private Limited | Bulk | 2025-09-25 |
Sell |
755.68 | 294,330 | NSE |
| Hrti Private Limited | Bulk | 2025-09-19 |
Purchase |
821.31 | 376,745 | NSE |
| Spdr Portfolio Emerging Markets Etf | Bulk | 2025-09-19 |
Purchase |
824.05 | 346,373 | NSE |
| Graviton Research Capital Llp | Bulk | 2025-09-19 |
Purchase |
821.32 | 248,631 | NSE |
| Hrti Private Limited | Bulk | 2025-09-19 |
Sell |
822.81 | 393,620 | NSE |
| Graviton Research Capital Llp | Bulk | 2025-09-19 |
Sell |
821.90 | 248,631 | NSE |
| Hrti Private Limited | Bulk | 2025-09-11 |
Purchase |
799.62 | 260,682 | NSE |
| Hrti Private Limited | Bulk | 2025-09-11 |
Sell |
806.18 | 252,556 | NSE |
| Hrti Private Limited | Bulk | 2025-09-09 |
Purchase |
826.44 | 230,421 | NSE |
| Hrti Private Limited | Bulk | 2025-09-09 |
Sell |
828.64 | 234,020 | NSE |
| Hrti Private Limited | Bulk | 2025-09-08 |
Purchase |
854.64 | 316,082 | NSE |
| Hrti Private Limited | Bulk | 2025-09-08 |
Sell |
857.18 | 313,768 | NSE |
| Graviton Research Capital Llp | Bulk | 2025-09-05 |
Purchase |
848.46 | 656,309 | NSE |
| Hrti Private Limited | Bulk | 2025-09-05 |
Purchase |
851.00 | 634,049 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-09-05 |
Purchase |
855.15 | 406,330 | NSE |
| Qe Securities Llp | Bulk | 2025-09-05 |
Purchase |
847.10 | 355,873 | NSE |
| Graviton Research Capital Llp | Bulk | 2025-09-05 |
Sell |
849.18 | 656,309 | NSE |
| Hrti Private Limited | Bulk | 2025-09-05 |
Sell |
855.33 | 651,636 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-09-05 |
Sell |
855.61 | 406,330 | NSE |
| Qe Securities Llp | Bulk | 2025-09-05 |
Sell |
844.76 | 374,627 | NSE |
| Graviton Research Capital Llp | Bulk | 2025-09-04 |
Purchase |
812.46 | 484,986 | NSE |
| Hrti Private Limited | Bulk | 2025-09-04 |
Purchase |
809.63 | 400,823 | NSE |
| Qe Securities Llp | Bulk | 2025-09-04 |
Purchase |
810.74 | 280,947 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-09-04 |
Purchase |
812.83 | 275,875 | NSE |
| Graviton Research Capital Llp | Bulk | 2025-09-04 |
Sell |
812.61 | 484,986 | NSE |
| Hrti Private Limited | Bulk | 2025-09-04 |
Sell |
812.68 | 434,862 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-09-04 |
Sell |
813.27 | 275,875 | NSE |
| Qe Securities Llp | Bulk | 2025-09-04 |
Sell |
810.61 | 270,372 | NSE |
| Graviton Research Capital Llp | Bulk | 2025-09-03 |
Purchase |
808.07 | 1,056,041 | NSE |
| Hrti Private Limited | Bulk | 2025-09-03 |
Purchase |
806.75 | 695,386 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-09-03 |
Purchase |
808.00 | 526,939 | NSE |
| Qe Securities Llp | Bulk | 2025-09-03 |
Purchase |
808.41 | 503,473 | NSE |
| Mathisys Advisors Llp | Bulk | 2025-09-03 |
Purchase |
806.55 | 409,238 | NSE |
| Alphagrep Securities Private Limited | Bulk | 2025-09-03 |
Purchase |
807.68 | 351,446 | NSE |
| Nk Securities Research Private Limited | Bulk | 2025-09-03 |
Purchase |
810.50 | 308,226 | NSE |
| Musigma Securities | Bulk | 2025-09-03 |
Purchase |
808.15 | 299,637 | NSE |
| Hrti Private Limited | Bulk | 2025-09-03 |
Purchase |
806.18 | 291,186 | BSE |
| Graviton Research Capital Llp | Bulk | 2025-09-03 |
Purchase |
807.03 | 264,357 | BSE |
| Graviton Research Capital Llp | Bulk | 2025-09-03 |
Sell |
808.48 | 1,056,041 | NSE |
| Hrti Private Limited | Bulk | 2025-09-03 |
Sell |
806.51 | 686,281 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-09-03 |
Sell |
808.43 | 526,939 | NSE |
| Qe Securities Llp | Bulk | 2025-09-03 |
Sell |
807.49 | 495,843 | NSE |
| Mathisys Advisors Llp | Bulk | 2025-09-03 |
Sell |
806.39 | 410,531 | NSE |
| Alphagrep Securities Private Limited | Bulk | 2025-09-03 |
Sell |
807.79 | 351,446 | NSE |
| Nk Securities Research Private Limited | Bulk | 2025-09-03 |
Sell |
810.91 | 308,226 | NSE |
| Hrti Private Limited | Bulk | 2025-09-03 |
Sell |
807.45 | 307,820 | BSE |
| Musigma Securities | Bulk | 2025-09-03 |
Sell |
808.48 | 299,637 | NSE |
| Graviton Research Capital Llp | Bulk | 2025-09-03 |
Sell |
807.30 | 264,357 | BSE |
| Hrti Private Limited | Bulk | 2025-09-02 |
Purchase |
735.97 | 917,339 | NSE |
| Musigma Securities | Bulk | 2025-09-02 |
Purchase |
750.59 | 669,185 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-09-02 |
Purchase |
740.83 | 616,662 | NSE |
| Nk Securities Research Private Limited | Bulk | 2025-09-02 |
Purchase |
754.89 | 340,151 | NSE |
| Qe Securities Llp | Bulk | 2025-09-02 |
Purchase |
734.09 | 339,734 | NSE |
| Growth Securities Private Limited | Bulk | 2025-09-02 |
Purchase |
743.94 | 258,290 | NSE |
| Hrti Private Limited | Bulk | 2025-09-02 |
Sell |
738.27 | 847,760 | NSE |
| Musigma Securities | Bulk | 2025-09-02 |
Sell |
750.82 | 669,185 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-09-02 |
Sell |
741.26 | 616,662 | NSE |
| Qe Securities Llp | Bulk | 2025-09-02 |
Sell |
732.62 | 357,149 | NSE |
| Nk Securities Research Private Limited | Bulk | 2025-09-02 |
Sell |
755.31 | 340,151 | NSE |
| Growth Securities Private Limited | Bulk | 2025-09-02 |
Sell |
743.80 | 258,290 | NSE |
| Hrti Private Limited | Bulk | 2025-08-20 |
Purchase |
690.07 | 252,475 | NSE |
| Hrti Private Limited | Bulk | 2025-08-20 |
Sell |
691.06 | 263,978 | NSE |
| Hrti Private Limited | Bulk | 2025-08-13 |
Purchase |
638.15 | 231,187 | NSE |
| Hrti Private Limited | Bulk | 2025-08-13 |
Sell |
641.06 | 243,239 | NSE |
| Hrti Private Limited | Bulk | 2025-08-08 |
Purchase |
643.40 | 347,335 | NSE |
| Aakraya Research Llp | Bulk | 2025-08-08 |
Purchase |
644.63 | 254,156 | NSE |
| Hrti Private Limited | Bulk | 2025-08-08 |
Sell |
645.67 | 376,589 | NSE |
| Aakraya Research Llp | Bulk | 2025-08-08 |
Sell |
644.84 | 254,156 | NSE |
| Hrti Private Limited | Bulk | 2025-08-07 |
Purchase |
647.13 | 807,137 | NSE |
| Aakraya Research Llp | Bulk | 2025-08-07 |
Purchase |
647.01 | 439,963 | NSE |
| Hrti Private Limited | Bulk | 2025-08-07 |
Purchase |
646.20 | 377,610 | BSE |
| Qe Securities Llp | Bulk | 2025-08-07 |
Purchase |
649.13 | 316,074 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-08-07 |
Purchase |
646.21 | 223,391 | NSE |
| Hrti Private Limited | Bulk | 2025-08-07 |
Sell |
646.53 | 855,889 | NSE |
| Aakraya Research Llp | Bulk | 2025-08-07 |
Sell |
647.42 | 439,963 | NSE |
| Hrti Private Limited | Bulk | 2025-08-07 |
Sell |
648.36 | 327,492 | BSE |
| Qe Securities Llp | Bulk | 2025-08-07 |
Sell |
649.14 | 321,542 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-08-07 |
Sell |
646.74 | 223,391 | NSE |
| Hrti Private Limited | Bulk | 2025-08-05 |
Purchase |
664.14 | 280,886 | NSE |
| Hrti Private Limited | Bulk | 2025-08-05 |
Sell |
664.09 | 302,727 | NSE |
| Hrti Private Limited | Bulk | 2025-08-04 |
Purchase |
657.84 | 432,677 | NSE |
| Aakraya Research Llp | Bulk | 2025-08-04 |
Purchase |
657.66 | 306,943 | NSE |
| Hrti Private Limited | Bulk | 2025-08-04 |
Sell |
659.65 | 406,620 | NSE |
| Aakraya Research Llp | Bulk | 2025-08-04 |
Sell |
657.87 | 306,943 | NSE |
| Hrti Private Limited | Bulk | 2025-08-01 |
Purchase |
701.85 | 689,657 | NSE |
| Aakraya Research Llp | Bulk | 2025-08-01 |
Purchase |
704.29 | 565,421 | NSE |
| Hrti Private Limited | Bulk | 2025-08-01 |
Purchase |
703.01 | 424,596 | BSE |
| Qe Securities Llp | Bulk | 2025-08-01 |
Purchase |
702.77 | 414,425 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-08-01 |
Purchase |
703.34 | 338,783 | NSE |
| Irage Broking Services Llp | Bulk | 2025-08-01 |
Purchase |
707.44 | 246,709 | NSE |
| Hrti Private Limited | Bulk | 2025-08-01 |
Sell |
704.64 | 696,777 | NSE |
| Aakraya Research Llp | Bulk | 2025-08-01 |
Sell |
704.74 | 565,421 | NSE |
| Hrti Private Limited | Bulk | 2025-08-01 |
Sell |
706.46 | 441,860 | BSE |
| Qe Securities Llp | Bulk | 2025-08-01 |
Sell |
704.06 | 414,225 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-08-01 |
Sell |
703.80 | 338,783 | NSE |
| Irage Broking Services Llp | Bulk | 2025-08-01 |
Sell |
703.16 | 221,262 | NSE |
| Hrti Private Limited | Bulk | 2025-07-31 |
Purchase |
689.39 | 1,003,370 | NSE |
| Aakraya Research Llp | Bulk | 2025-07-31 |
Purchase |
690.59 | 884,493 | NSE |
| Qe Securities Llp | Bulk | 2025-07-31 |
Purchase |
693.14 | 507,550 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-07-31 |
Purchase |
690.02 | 445,966 | NSE |
| Irage Broking Services Llp | Bulk | 2025-07-31 |
Purchase |
688.18 | 424,070 | NSE |
| Nk Securities Research Private Limited | Bulk | 2025-07-31 |
Purchase |
690.48 | 315,752 | NSE |
| Irage Broking Services Llp | Bulk | 2025-07-31 |
Purchase |
687.78 | 291,002 | BSE |
| Growth Securities Private Limited | Bulk | 2025-07-31 |
Purchase |
687.94 | 236,324 | NSE |
| Hrti Private Limited | Bulk | 2025-07-31 |
Purchase |
681.03 | 196,041 | BSE |
| Hrti Private Limited | Bulk | 2025-07-31 |
Sell |
690.04 | 1,004,377 | NSE |
| Aakraya Research Llp | Bulk | 2025-07-31 |
Sell |
691.07 | 884,493 | NSE |
| Qe Securities Llp | Bulk | 2025-07-31 |
Sell |
693.41 | 507,808 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-07-31 |
Sell |
690.42 | 445,966 | NSE |
| Irage Broking Services Llp | Bulk | 2025-07-31 |
Sell |
688.59 | 387,002 | BSE |
| Irage Broking Services Llp | Bulk | 2025-07-31 |
Sell |
688.36 | 328,070 | NSE |
| Nk Securities Research Private Limited | Bulk | 2025-07-31 |
Sell |
690.92 | 315,752 | NSE |
| Hrti Private Limited | Bulk | 2025-07-31 |
Sell |
690.17 | 263,816 | BSE |
| Growth Securities Private Limited | Bulk | 2025-07-31 |
Sell |
688.03 | 236,324 | NSE |
| Hrti Private Limited | Bulk | 2025-07-30 |
Purchase |
677.08 | 648,678 | NSE |
| Aakraya Research Llp | Bulk | 2025-07-30 |
Purchase |
677.63 | 499,722 | NSE |
| Hrti Private Limited | Bulk | 2025-07-30 |
Purchase |
678.77 | 350,554 | BSE |
| Qe Securities Llp | Bulk | 2025-07-30 |
Purchase |
677.65 | 289,738 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-07-30 |
Purchase |
676.76 | 277,192 | NSE |
| Hrti Private Limited | Bulk | 2025-07-30 |
Sell |
680.40 | 642,699 | NSE |
| Aakraya Research Llp | Bulk | 2025-07-30 |
Sell |
678.02 | 499,722 | NSE |
| Hrti Private Limited | Bulk | 2025-07-30 |
Sell |
680.30 | 363,160 | BSE |
| Qe Securities Llp | Bulk | 2025-07-30 |
Sell |
679.24 | 289,328 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-07-30 |
Sell |
677.08 | 277,192 | NSE |
| Graviton Research Capital Llp | Bulk | 2025-07-29 |
Purchase |
692.47 | 2,042,551 | NSE |
| Hrti Private Limited | Bulk | 2025-07-29 |
Purchase |
692.62 | 1,158,822 | NSE |
| Qe Securities Llp | Bulk | 2025-07-29 |
Purchase |
692.72 | 1,117,196 | NSE |
| Aakraya Research Llp | Bulk | 2025-07-29 |
Purchase |
692.92 | 994,219 | NSE |
| Alphagrep Securities Private Limited | Bulk | 2025-07-29 |
Purchase |
694.44 | 544,697 | NSE |
| Nk Securities Research Private Limited | Bulk | 2025-07-29 |
Purchase |
693.45 | 497,617 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-07-29 |
Purchase |
692.15 | 435,794 | NSE |
| Qe Securities Llp | Bulk | 2025-07-29 |
Purchase |
688.96 | 423,861 | BSE |
| Musigma Securities | Bulk | 2025-07-29 |
Purchase |
702.62 | 405,802 | NSE |
| Irage Broking Services Llp | Bulk | 2025-07-29 |
Purchase |
689.99 | 353,058 | NSE |
| Hrti Private Limited | Bulk | 2025-07-29 |
Purchase |
689.08 | 346,842 | BSE |
| Dipan Mehta Commodities Private Limited | Bulk | 2025-07-29 |
Purchase |
697.78 | 336,885 | NSE |
| Microcurves Trading Private Limited | Bulk | 2025-07-29 |
Purchase |
691.76 | 326,229 | NSE |
| Elixir Wealth Management Private Limited | Bulk | 2025-07-29 |
Purchase |
695.69 | 309,277 | NSE |
| Graviton Research Capital Llp | Bulk | 2025-07-29 |
Purchase |
688.49 | 248,122 | BSE |
| Irage Broking Services Llp | Bulk | 2025-07-29 |
Purchase |
692.87 | 237,333 | BSE |
| Graviton Research Capital Llp | Bulk | 2025-07-29 |
Sell |
692.86 | 2,042,551 | NSE |
| Hrti Private Limited | Bulk | 2025-07-29 |
Sell |
692.90 | 1,145,540 | NSE |
| Qe Securities Llp | Bulk | 2025-07-29 |
Sell |
692.93 | 1,123,064 | NSE |
| Aakraya Research Llp | Bulk | 2025-07-29 |
Sell |
693.24 | 994,219 | NSE |
| Alphagrep Securities Private Limited | Bulk | 2025-07-29 |
Sell |
694.26 | 544,697 | NSE |
| Nk Securities Research Private Limited | Bulk | 2025-07-29 |
Sell |
693.91 | 497,617 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-07-29 |
Sell |
692.36 | 435,794 | NSE |
| Qe Securities Llp | Bulk | 2025-07-29 |
Sell |
688.86 | 417,979 | BSE |
| Musigma Securities | Bulk | 2025-07-29 |
Sell |
702.96 | 405,802 | NSE |
| Hrti Private Limited | Bulk | 2025-07-29 |
Sell |
687.32 | 337,621 | BSE |
| Dipan Mehta Commodities Private Limited | Bulk | 2025-07-29 |
Sell |
698.54 | 332,385 | NSE |
| Microcurves Trading Private Limited | Bulk | 2025-07-29 |
Sell |
692.17 | 326,229 | NSE |
| Elixir Wealth Management Private Limited | Bulk | 2025-07-29 |
Sell |
696.37 | 307,192 | NSE |
| Irage Broking Services Llp | Bulk | 2025-07-29 |
Sell |
689.86 | 305,599 | BSE |
| Irage Broking Services Llp | Bulk | 2025-07-29 |
Sell |
693.28 | 284,792 | NSE |
| Graviton Research Capital Llp | Bulk | 2025-07-29 |
Sell |
689.12 | 248,122 | BSE |
| Graviton Research Capital Llp | Bulk | 2025-07-28 |
Purchase |
632.18 | 2,072,243 | NSE |
| Hrti Private Limited | Bulk | 2025-07-28 |
Purchase |
632.80 | 1,057,732 | NSE |
| Musigma Securities | Bulk | 2025-07-28 |
Purchase |
639.42 | 1,029,733 | NSE |
| Qe Securities Llp | Bulk | 2025-07-28 |
Purchase |
632.48 | 845,307 | NSE |
| Aakraya Research Llp | Bulk | 2025-07-28 |
Purchase |
633.37 | 812,358 | NSE |
| Alphagrep Securities Private Limited | Bulk | 2025-07-28 |
Purchase |
636.23 | 621,103 | NSE |
| Elixir Wealth Management Private Limited | Bulk | 2025-07-28 |
Purchase |
639.36 | 510,000 | NSE |
| Irage Broking Services Llp | Bulk | 2025-07-28 |
Purchase |
632.04 | 499,098 | NSE |
| Microcurves Trading Private Limited | Bulk | 2025-07-28 |
Purchase |
630.24 | 401,682 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-07-28 |
Purchase |
631.64 | 394,843 | NSE |
| Hrti Private Limited | Bulk | 2025-07-28 |
Purchase |
630.76 | 385,037 | BSE |
| Share India Securities Limited | Bulk | 2025-07-28 |
Purchase |
647.72 | 356,970 | NSE |
| Qe Securities Llp | Bulk | 2025-07-28 |
Purchase |
632.23 | 349,814 | BSE |
| Graviton Research Capital Llp | Bulk | 2025-07-28 |
Purchase |
632.11 | 342,296 | BSE |
| Irage Broking Services Llp | Bulk | 2025-07-28 |
Purchase |
637.40 | 307,835 | BSE |
| Nk Securities Research Private Limited | Bulk | 2025-07-28 |
Purchase |
639.69 | 304,584 | NSE |
| Graviton Research Capital Llp | Bulk | 2025-07-28 |
Sell |
632.67 | 2,072,243 | NSE |
| Musigma Securities | Bulk | 2025-07-28 |
Sell |
639.60 | 1,029,733 | NSE |
| Hrti Private Limited | Bulk | 2025-07-28 |
Sell |
636.83 | 931,111 | NSE |
| Qe Securities Llp | Bulk | 2025-07-28 |
Sell |
634.30 | 854,668 | NSE |
| Aakraya Research Llp | Bulk | 2025-07-28 |
Sell |
633.76 | 812,358 | NSE |
| Alphagrep Securities Private Limited | Bulk | 2025-07-28 |
Sell |
636.45 | 621,103 | NSE |
| Elixir Wealth Management Private Limited | Bulk | 2025-07-28 |
Sell |
640.07 | 510,000 | NSE |
| Hrti Private Limited | Bulk | 2025-07-28 |
Sell |
632.78 | 453,952 | BSE |
| Irage Broking Services Llp | Bulk | 2025-07-28 |
Sell |
631.23 | 443,506 | BSE |
| Microcurves Trading Private Limited | Bulk | 2025-07-28 |
Sell |
630.43 | 401,682 | NSE |
| Junomoneta Finsol Private Limited | Bulk | 2025-07-28 |
Sell |
631.90 | 394,843 | NSE |
| Irage Broking Services Llp | Bulk | 2025-07-28 |
Sell |
638.31 | 363,246 | NSE |
| Share India Securities Limited | Bulk | 2025-07-28 |
Sell |
648.87 | 356,971 | NSE |
| Graviton Research Capital Llp | Bulk | 2025-07-28 |
Sell |
632.83 | 342,300 | BSE |
| Qe Securities Llp | Bulk | 2025-07-28 |
Sell |
632.00 | 340,469 | BSE |
| Nk Securities Research Private Limited | Bulk | 2025-07-28 |
Sell |
640.12 | 304,584 | NSE |
| Nk Securities Research Private Limited | Bulk | 2025-07-25 |
Purchase |
574.91 | 765,007 | NSE |
| Qe Securities Llp | Bulk | 2025-07-25 |
Purchase |
567.63 | 457,315 | NSE |
| Aakraya Research Llp | Bulk | 2025-07-25 |
Purchase |
571.59 | 454,578 | NSE |
| Musigma Securities | Bulk | 2025-07-25 |
Purchase |
578.99 | 445,232 | NSE |
| Hrti Private Limited | Bulk | 2025-07-25 |
Purchase |
564.71 | 391,905 | NSE |
| Graviton Research Capital Llp | Bulk | 2025-07-25 |
Purchase |
555.79 | 269,144 | NSE |
| Irage Broking Services Llp | Bulk | 2025-07-25 |
Purchase |
578.18 | 256,924 | NSE |
| Elixir Wealth Management Private Limited | Bulk | 2025-07-25 |
Purchase |
576.09 | 242,244 | NSE |
| Nk Securities Research Private Limited | Bulk | 2025-07-25 |
Sell |
575.45 | 765,007 | NSE |
| Qe Securities Llp | Bulk | 2025-07-25 |
Sell |
567.72 | 466,373 | NSE |
Client name |
Client Category |
Action |
Reported to Exchange |
Quantity |
Post Transaction Holding |
Avg. Price |
Regulation (Insider/SAST) |
Mode |
|---|---|---|---|---|---|---|---|---|
| Jagadeesh Kodali | Designated Person |
Disposal |
2026-03-10 | 5,000 | 10,028 | 464.00 | Insider Trading | Gift |
| Jagadeesh Kodali | Designated Person |
Disposal |
2026-03-10 | 5,000 | 10,028 | 464.00 | Insider Trading | Gift |
| Harriman Vungal | Promoter & Director |
Disposal |
2025-08-11 | 10,000 | 3,085,636 | 649.25 | Insider Trading | Gift |
| Harriman Vungal & Others | Promoter |
Acquisition |
2025-07-15 | 450,000 | 4,134,954 | SAST 29(2) | Off Market | |
| Vungal Rajeswari | Promoter Group |
Acquisition |
2025-07-02 | 250,000 | 411,450 | 438.20 | Insider Trading | Gift |
| Sireesh Chandra Vungal | Promoter Group |
Acquisition |
2025-07-02 | 100,000 | 326,110 | 438.20 | Insider Trading | Gift |
| Sudheshna Vungal | Promoter Group |
Acquisition |
2025-07-02 | 100,000 | 301,758 | 438.20 | Insider Trading | Gift |
| Harriman Vungal | Promoter & Director |
Disposal |
2025-07-02 | 450,000 | 3,095,636 | 438.20 | Insider Trading | Gift |
| Vasireddi Veerabhadra Prasad & Others | Promoter |
Acquisition |
2025-06-16 | 950,000 | 1,532,140 | SAST 29(2) | Off Market | |
| Sujani Vasireddi | Promoter Group |
Acquisition |
2025-06-02 | 350,000 | 416,325 | 976.40 | Insider Trading | Gift |
| Vasireddi Veerabhadra Prasad | Promoter |
Disposal |
2025-06-02 | 950,000 | 513,515 | 976.40 | Insider Trading | Gift |
| Rajya Lakshmi Vasireddi | Promoter Group |
Acquisition |
2025-06-02 | 600,000 | 602,300 | 976.40 | Insider Trading | Gift |
| Harriman Vungal | Promoter |
Disposal |
2025-02-17 | 2,900 | 1,772,818 | 1,083.66 | Insider Trading | Market Sale |
| Harriman Vungal | Promoter |
Disposal |
2025-02-12 | 975 | 1,776,918 | 1,038.00 | Insider Trading | Market Sale |
| Harriman Vungal | Promoter |
Disposal |
2025-02-12 | 1,200 | 1,775,718 | Insider Trading | Gift | |
| Ravi Kumar Kunuguntla | Designated Person |
Disposal |
2024-12-04 | 2,018 | 7,400 | 853.11 | Insider Trading | Market Sale |
| Suresh Kumar S | Designated Person |
Disposal |
2024-11-27 | 1,400 | 100 | 801.65 | Insider Trading | Market Sale |
| Sujani Vasireddi | Promoter Group |
Disposal |
2024-11-27 | 7,000 | 68,325 | 828.18 | Insider Trading | Market Sale |
| Sujani Vasireddi | Promoter Group |
Disposal |
2024-11-19 | 5,064 | 75,325 | 759.25 | Insider Trading | Market Sale |
| D R Narahai Naidu | KMP |
Disposal |
2024-11-19 | 3,659 | 10 | 767.35 | Insider Trading | Market Sale |
| Dr Muni Nagendra Prasad Poola | Designated Person |
Disposal |
2024-11-19 | 886 | 382 | 760.19 | Insider Trading | Market Sale |
| Suresh Kumar S | Designated Person |
Disposal |
2024-11-19 | 1,500 | 1,500 | 743.33 | Insider Trading | Market Sale |
| Dr Muni Nagendra Prasad Poola | Designated Person |
Disposal |
2024-09-17 | 2,535 | 0 | 539.59 | Insider Trading | Market Sale |
| Sujani Vasireddi | Promoter Group |
Disposal |
2024-06-26 | 7,153 | 80,389 | 492.92 | Insider Trading | Market Sale |
| Sujani Vasireddi | Promoter Group |
Disposal |
2024-02-28 | 10,000 | 87,542 | 508.56 | Insider Trading | Market Sale |
| Suresh Kumar | Designated Person |
Disposal |
2024-02-26 | 2,000 | 3,000 | 490.75 | Insider Trading | Market Sale |
| Praveen Vasireddi | Promoter |
Acquisition |
2023-11-23 | 1,000,000 | 1,102,535 | SAST 29(2) | Gift | |
| Praveena Vasireddi | Promoter Group |
Acquisition |
2023-11-17 | 1,000,000 | 1,102,535 | Insider Trading | Gift | |
| Sivalinga Prasad Vasireddi | Promoter & Director |
Disposal |
2023-11-17 | 1,000,000 | 2,598,525 | Insider Trading | Gift | |
| Sujani Vasireddi | Promoter Group |
Disposal |
2023-08-21 | 18,234 | 97,542 | 527.47 | Insider Trading | Market Sale |
| Sujani Vasireddi | Promoter Group |
Disposal |
2023-08-17 | 4,766 | 115,776 | 520.00 | Insider Trading | Market Sale |
| Praveena Vasireddi | Promoter Group |
Disposal |
2023-08-17 | 10,000 | 102,535 | 510.00 | Insider Trading | Market Sale |
| Sujani Vasireddi | Promoter Group |
Disposal |
2023-08-16 | 2,000 | 120,542 | 519.22 | Insider Trading | Market Sale |
| Jagadeesh Kodali | Designated Person |
Disposal |
2023-08-12 | 4,514 | 0 | 493.11 | Insider Trading | Market Sale |
| Praveena Vasireddi | Promoter Group |
Disposal |
2023-08-11 | 10,000 | 112,535 | 490.00 | Insider Trading | Market Sale |
| Praveena Vasireddi | Promoter Group |
Disposal |
2023-01-03 | 15 | 122,535 | 440.00 | Insider Trading | Market Sale |
| Suresh Kumar | Designated Person |
Disposal |
2022-11-24 | 5,000 | 0 | 462.64 | Insider Trading | Market Sale |
| Rajya Lakshmi Vasireddi | Promoter Group |
Disposal |
2022-11-03 | 40,000 | 2,300 | 407.46 | Insider Trading | Market Sale |
About Vimta Labs Ltd
Stock PE (TTM)
34.2
Promoter Holding
35.67%
Book Value
102.2104
ROCE
23.21%
ROE
18.55%
Vimta Labs Limited., established in 1984, is India`s most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas like preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products. In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia. During 2002, the company began to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials. During the year 2006-07, the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S.P.Biotech Park, Genome Valley, Hyderabad which started commercial operations from September, 2006. During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited, on 04th March 2020, making Emtac a wholly owned subsidiary of the Company. In 2024-25, Emtac Laboratories Pvt. Ltd., the 100% owned subsidiary got merged with the Company effective from 01 April, 2024, thereby consolidating its presence in the Electronics and Electrical testing. The Company has entered into niche segment of contract research & development of biologics and peptides in FY2025-26. The Memorandum of Association (MoA) of the Company was amended, with the Main Object Clause to undertake activities in the Biologics Contract Research and Development and Manufacturing (CDMO) segment, including contract development, analytical testing, and other R&D services relating to biologics and peptide-based drug development and manufacturing support in FY 2025-26.
Vimta Labs share price as on 23 Sep 2026 is Rs. 610.15. Over the past 6 months, the Vimta Labs share price has increased by 42.83% and in the last one year, it has decreased by 20.16%. The 52-week low for Vimta Labs share price was Rs. 376.05 and 52-week high was Rs. 775.
Registered Office
Plot No 141/2 & 142, IDA Phase II Cherlapally, Hyderabad, Telangana, 500051
Tel No. 91-40-27264141
Email shares:vimta.com
Registrars
CIL Securities Limited
Tel No. 91-040-23202465/2320
Email cilsec:hotmail.com
Management
Executive Director (Operation)
Independent Non Exe. Director
Independent Non Exe. Director
Independent Non Exe. Director
Managing Director
Executive Chairman
Company Sec. & Compli. Officer
Independent Non Exe. Director
Executive Director
Listing Info
524394
VIMTALABS
INE579C01029
Jun
Vimta Labs Ltd FAQs
You can buy Vimta Labs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Vimta Labs Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Sep 22, 2026 03:59 PM the closing price of Vimta Labs Ltd was Rs.610.15.
The latest PE ratio of Vimta Labs Ltd as of Sep 22, 2026 03:59 PM is 34.20
The latest PB ratio of Vimta Labs Ltd as of Sep 22, 2026 03:59 PM is 5.97
The 52-week high of Vimta Labs Ltd share price is Rs. 775.00 while the 52-week low is Rs. 376.05
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Sep 22, 2026 03:59 PM, the market cap of Vimta Labs Ltd stood at Rs. 2,725.48 Cr.
Market Outlook
View allNo news to display.
